Paper17536871
Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
Lenoir G and 7 others. Paediatr Drugs, 2007. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Papers, record 17536871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17536871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Cystic Fibrosis | Major topic |
| Pseudomonas Infections | Major topic |
| Tobramycin | Major topic |
| Administration, Inhalation | |
| Adolescent | |
| Adult | |
| Child | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Nebulizers and Vaporizers | |
| Prospective Studies | |
| Pseudomonas aeruginosa | |
| Treatment Outcome |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8575589 | Inhalation of antibiotics in cystic fibrosis. | Eur Respir J | 1995 | https://conductscience.org/library/papers/8575589 | PubMed |
| 2 | 3117701 | Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa. | Infection | 1987 | https://conductscience.org/library/papers/3117701 | PubMed |
| 3 | 8497284 | Efficacy of aerosolized tobramycin in patients with cystic fibrosis. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8497284 | PubMed |
| 4 | 2109790 | Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. | J Pediatr | 1990 | https://conductscience.org/library/papers/2109790 | PubMed |
| 5 | 17536870 | Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi. | Paediatr Drugs | 2007 | https://conductscience.org/library/papers/17536870 | PubMed |
| 6 | 2816859 | Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry. | Am J Dis Child | 1989 | https://conductscience.org/library/papers/2816859 | PubMed |
| 7 | 12091173 | Spirometry in 3- to 6-year-old children with cystic fibrosis. | Am J Respir Crit Care Med | 2002 | https://conductscience.org/library/papers/12091173 | PubMed |
| 8 | 12527599 | Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system. | Chest | 2003 | https://conductscience.org/library/papers/12527599 | PubMed |
| 9 | 12480612 | Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. | Am J Respir Crit Care Med | 2003 | https://conductscience.org/library/papers/12480612 | PubMed |
| 10 | 15463837 | Inhaled antibiotic therapy in evidence: what delivery device? | J Cyst Fibros | 2002 | https://conductscience.org/library/papers/15463837 | PubMed |
| 11 | 12358344 | A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. | Eur Respir J | 2002 | https://conductscience.org/library/papers/12358344 | PubMed |
| 12 | 9041399 | Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. | J Clin Microbiol | 1997 | https://conductscience.org/library/papers/9041399 | PubMed |
| 13 | 1539140 | Use of induced sputum cell counts to investigate airway inflammation in asthma. | Thorax | 1992 | https://conductscience.org/library/papers/1539140 | PubMed |
| 14 | 10536249 | Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer. | Int J Pharm | 1999 | https://conductscience.org/library/papers/10536249 | PubMed |
| 15 | 6859656 | Changes in the normal maximal expiratory flow-volume curve with growth and aging. | Am Rev Respir Dis | 1983 | https://conductscience.org/library/papers/6859656 | PubMed |
| 16 | 1549817 | Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. | Thorax | 1992 | https://conductscience.org/library/papers/1549817 | PubMed |
| 17 | 11129122 | The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? | Drugs | 2000 | https://conductscience.org/library/papers/11129122 | PubMed |
| 18 | 7481201 | Biostatistical methodology in clinical trials--a European guideline. | Stat Med | 1995 | https://conductscience.org/library/papers/7481201 | PubMed |
| 19 | 11796432 | Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. | Chest | 2002 | https://conductscience.org/library/papers/11796432 | PubMed |
| 20 | 9878641 | Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. | N Engl J Med | 1999 | https://conductscience.org/library/papers/9878641 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40223951 | Comparative efficacy and safety of inhaled antibiotics in managing chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis and bronchiectasis: a systematic review and network meta-analysis. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40223951 | PubMed |
| 40001409 | Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40001409 | PubMed |
| 39648822 | Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies. | J Aerosol Med Pulm Drug Deliv | 2025 | https://conductscience.org/library/papers/39648822 | PubMed |
| 37268599 | Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37268599 | PubMed |
| 37194817 | Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association). | J Bras Pneumol | 2023 | https://conductscience.org/library/papers/37194817 | PubMed |
| 36978351 | Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36978351 | PubMed |
| 36373968 | Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36373968 | PubMed |
| 35914011 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35914011 | PubMed |
| 34438986 | Therapeutic Approach of Chronic Pseudomonas Infection in Cystic Fibrosis-A Network Meta-Analysis. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34438986 | PubMed |
| 33486720 | Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/33486720 | PubMed |
| 30376155 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30376155 | PubMed |
| 30288426 | Shared Decision-Making Tool for Self-Management of Home Therapies for Patients With Cystic Fibrosis. | MDM Policy Pract | 2017 | https://conductscience.org/library/papers/30288426 | PubMed |
| 29607494 | Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29607494 | PubMed |
| 28440853 | Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28440853 | PubMed |
| 25792839 | Long-term safety and efficacy of tobramycin in the management of cystic fibrosis. | Ther Clin Risk Manag | 2015 | https://conductscience.org/library/papers/25792839 | PubMed |
| 25278817 | Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. | Core Evid | 2014 | https://conductscience.org/library/papers/25278817 | PubMed |
| 25278574 | Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. | Clin Microbiol Rev | 2014 | https://conductscience.org/library/papers/25278574 | PubMed |
| 24489509 | Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis. | ScientificWorldJournal | 2013 | https://conductscience.org/library/papers/24489509 | PubMed |
| 24476418 | Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis. | Ann Am Thorac Soc | 2014 | https://conductscience.org/library/papers/24476418 | PubMed |
| 22915944 | Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review. | Med Devices (Auckl) | 2011 | https://conductscience.org/library/papers/22915944 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17536871
GET https://conductscience.org/api/papers/v1/17536871/references?page=2